FDA Nominee Addresses Vaccine Safety During Senate Hearing

Why it matters locally: The FDA's policies on vaccine safety and childhood immunizations directly impact public health and healthcare practices across Iowa. Decisions made by the FDA can influence vaccine availability, recommendations, and public health campaigns within the state.

---

WASHINGTON – Heidi Overton, President Donald Trump's nominee to lead the Food and Drug Administration (FDA), spoke to senators Thursday during her confirmation hearing. Overton addressed the safety of long-established vaccines. Senators questioned Overton on the White House's initiatives regarding childhood immunizations. Her testimony followed President Trump's nomination for the FDA's top role.